Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1134907

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	100,000 Genomes Project
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to evaluate the 100,000 Genomes Project.
	tabling member constituency	Birmingham, Yardley
	tabling member printed	Jess Phillips
	uin	269788
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>As a Government Major Project, the 100,000 Genomes Project has been under regular review by the Infrastructure and Projects Authority (IPA) which provides independent assurance of the most complex and strategically significant projects across Government. As part of this, the 100,000 Genomes Project has undergone several significant reviews which considered the Project’s delivery, requiring the collation of extensive documentation evidencing the progress of the Project and several days of interviews with key stakeholders. Conclusions of each review were shared across delivery partners to inform successful delivery of the Project.</p><p>The Department, Genomics England and NHS England recognised the importance in embedding robust testing, assessment and evaluation throughout the delivery of the Project to inform the introduction of whole genome sequencing in the National Health Service under the new Genomics Medicine Service.</p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 05/07/2019 11:40:47 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4370 label Biography information for Jess Phillips

1134669

	registered interest
	date	25/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Abortion
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether there are any circumstances in which a pregnancy that does not (1) pose a risk to the physical health of a mother, and (2) involve a foetus that has been diagnosed with a disability, can be involuntarily terminated.
	tabling member printed	Lord Alton of Liverpool
	uin	HL16636
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>A decision to terminate a pregnancy must comply with the legal requirements of the Abortion Act 1967. In circumstances where a person lacks capacity, the courts have the authority to make serious healthcare and treatment decisions, in the best interests of the person and pursuant to the Mental Capacity Act 2005, and this could include whether a pregnancy should be terminated.</p> answering member printed Baroness Blackwood of North Oxford question first answered 05/07/2019 10:55:39 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	738 label Biography information for Lord Alton of Liverpool

1134829

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what research his Department has undertaken (a) directly, (b) through research councils and (c) with international partners on antimicrobial resistance.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	269618
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>The Department is investing over £1 billion a year in health research through the National Institute for Health Research (NIHR). The NIHR supports a wide portfolio of research on antimicrobial resistance (AMR) through various funding streams. In the United Kingdom, investment includes £32 million of capital funding to support AMR research, £19.1 million for AMR research at four NIHR Biomedical Research Centres, and £8.8 million for two NIHR Health Protection Research Units on Healthcare Associated Infections and Antimicrobial Resistance.</p><p>The NIHR also supports research into AMR in low and middle-income countries (LMICs), with official development assistance (ODA) funding through the NIHR Global Health Research programme. Investment includes support for the NIHR Global Health Research Unit on Genomic Surveillance of Antimicrobial Resistance, and the NIHR Global Health Research Group on Genomic Surveillance of Malaria in West Africa.</p><p>Working through partnerships with other UK funders, the NIHR Global Health Research programme also supports cross-Research Council initiatives including one led by the Medical Research Council for research into AMR in a global context, and another led by the Economic and Social Research Council to expand understanding of how behaviour within and beyond the healthcare system impacts on AMR.</p><p>In addition, the Department has allocated over £50 million of ODA over five years to AMR research through the Global AMR Innovation Fund. This research is delivered through a range of mechanisms and delivery partners, including research councils such as the Biotechnology and Biological Sciences Research Council and Innovate UK, and international partners including the Wellcome Trust, Bill and Melinda Gates Foundation, the United States and German governments, and Canada’s International Development Research Centre.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 05/07/2019 11:34:34 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	252 label Biography information for Dr David Drew

1134876

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the cost is of a single whole genome sequencing test for (a) blood cancers and (b) other cancer types.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	269721
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>The National Genomic Test Directory outlines which genomic tests are commissioned by the National Health Service in England, the technology by which they are available, and the patients who will be eligible to access to a test. The Directory will be updated on an annual basis and NHS England will implement a clear and transparent process, supported by a Clinical and Scientific Expert Panel, to determine which tests are available within the NHS. This will include reviewing any tests that may be retired or replaced by more modern technology, such as whole genome sequencing. As the price of whole genome sequencing falls and the clinical evidence improves, we envisage that it will be extended to more conditions and therefore more patients. More information on the Directory is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/national-genomic-test-directories/" target="_blank">https://www.england.nhs.uk/publication/national-genomic-test-directories/</a></p><p> </p><p>There is considerable variation in the reported costs of genomic analysis. For Genomics England, during the 100,000 Genomes project, these were in order of £2,500 per cancer patient. This included sequencing both the patient’s normal genome and their tumour, as well as the running costs of undertaking both the sequencing and bioinformatics for analysis and interpretation.</p><p>Health Education England established the Genomics Education Programme to support NHS staff to build the knowledge, skills and experience to deliver a whole genome sequencing service. This programme is being embedded into organisations to enable long-term sustainability of the multi-disciplinary clinical workforce.</p><p> </p><p> </p><p> </p><p> </p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 269720 269722 question first answered 05/07/2019 09:26:34 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4056 label Biography information for Nic Dakin

1134899

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Commissioning Groups
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS long-term plan, what assessment he has made of the potential effect on healthcare delivery of reducing the number of clinical commissioning groups to match the number of sustainability and transformation partnerships.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	269781
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>Sustainability and transformation partnerships (STPs) and integrated care systems (ICS) are fundamentally about bringing National Health Service providers, commissioners, local authorities, and other health and care services together to propose how they, at local level, can improve the way that health and care is planned and delivered in a more person-centred and coordinated way.</p><p>The most developed STPs have evolved into ICS, an even closer partnership between NHS organisations, local councils and other relevant organisations, which take collective responsibility for managing resources, delivering NHS standards, and improving the health of the population they serve.</p><p>The NHS Long Term Plan set out the ambition for ICS to cover the whole of England by April 2021. The NHS Long Term Plan sets out that “every ICS will need streamlined commissioning arrangements to enable a single set of commissioning decisions at system level. This will typically involve a single Clinical Commissioning Group (CCG) for each ICS area”. However, this will need to reflect local circumstances, and NHS England is not intending to impose this centrally. NHS England is working with ICS and local areas to determine the best configuration of CCGs.</p><p>CCGs have a legal right to apply for a merger and it is for NHS England to decide whether to approve a merger. This is an operational decision, and so sits with NHS England. There are a number of specific legal factors and further criteria that NHS England will consider when deciding whether to agree the merger. The application process and criteria applied for CCG mergers is available in the Procedures for clinical commissioning groups to apply for constitution change, merger or dissolution guidance.</p><p>The criteria include the proposed new CCG demonstrating alignment with (or within) the local STP/ICS to provide the most logical footprint for local implementation of the NHS Long Term Plan. CCGs must also include evidence of providing strategic, integrated commissioning to support population health; whilst ensuring that the move to a larger geographical footprint will not be at the expense of local accountability, or the proposed new CCG’s ability to engage with, and consider the needs of, local communities. Before a merger takes place, the CCG must also demonstrate that they have engaged with and seriously considered the views of their local general practitioners and local Healthwatch. In all cases, CCGs’ legal accountability to NHS England remains the same, regardless of the size of the CCG.</p><p>More broadly, we support NHS England’s intention to streamline commissioning arrangements, as NHS England expect that this will make it easier for the NHS to manage resources, make strategic decisions, and reduce unnecessary bureaucracy.</p><p> </p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 269782 269783 269784 269785 question first answered 05/07/2019 13:24:50 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4620 label Biography information for Ellie Reeves

1134900

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Commissioning Groups
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS long-term plan, what assessment he has made of the potential (a) merits and (b) demerits of reducing the number of clinical commissioning groups to match the number of sustainability and transformation partnerships.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	269782
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>Sustainability and transformation partnerships (STPs) and integrated care systems (ICS) are fundamentally about bringing National Health Service providers, commissioners, local authorities, and other health and care services together to propose how they, at local level, can improve the way that health and care is planned and delivered in a more person-centred and coordinated way.</p><p>The most developed STPs have evolved into ICS, an even closer partnership between NHS organisations, local councils and other relevant organisations, which take collective responsibility for managing resources, delivering NHS standards, and improving the health of the population they serve.</p><p>The NHS Long Term Plan set out the ambition for ICS to cover the whole of England by April 2021. The NHS Long Term Plan sets out that “every ICS will need streamlined commissioning arrangements to enable a single set of commissioning decisions at system level. This will typically involve a single Clinical Commissioning Group (CCG) for each ICS area”. However, this will need to reflect local circumstances, and NHS England is not intending to impose this centrally. NHS England is working with ICS and local areas to determine the best configuration of CCGs.</p><p>CCGs have a legal right to apply for a merger and it is for NHS England to decide whether to approve a merger. This is an operational decision, and so sits with NHS England. There are a number of specific legal factors and further criteria that NHS England will consider when deciding whether to agree the merger. The application process and criteria applied for CCG mergers is available in the Procedures for clinical commissioning groups to apply for constitution change, merger or dissolution guidance.</p><p>The criteria include the proposed new CCG demonstrating alignment with (or within) the local STP/ICS to provide the most logical footprint for local implementation of the NHS Long Term Plan. CCGs must also include evidence of providing strategic, integrated commissioning to support population health; whilst ensuring that the move to a larger geographical footprint will not be at the expense of local accountability, or the proposed new CCG’s ability to engage with, and consider the needs of, local communities. Before a merger takes place, the CCG must also demonstrate that they have engaged with and seriously considered the views of their local general practitioners and local Healthwatch. In all cases, CCGs’ legal accountability to NHS England remains the same, regardless of the size of the CCG.</p><p>More broadly, we support NHS England’s intention to streamline commissioning arrangements, as NHS England expect that this will make it easier for the NHS to manage resources, make strategic decisions, and reduce unnecessary bureaucracy.</p><p> </p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 269781 269783 269784 269785 question first answered 05/07/2019 13:24:50 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4620 label Biography information for Ellie Reeves

1134901

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Commissioning Groups
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS long-term plan, what consultation his Department has conducted on the potential merits of reducing the number of clinical commissioning groups to match the number of sustainability and transformation partnerships.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	269783
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>Sustainability and transformation partnerships (STPs) and integrated care systems (ICS) are fundamentally about bringing National Health Service providers, commissioners, local authorities, and other health and care services together to propose how they, at local level, can improve the way that health and care is planned and delivered in a more person-centred and coordinated way.</p><p>The most developed STPs have evolved into ICS, an even closer partnership between NHS organisations, local councils and other relevant organisations, which take collective responsibility for managing resources, delivering NHS standards, and improving the health of the population they serve.</p><p>The NHS Long Term Plan set out the ambition for ICS to cover the whole of England by April 2021. The NHS Long Term Plan sets out that “every ICS will need streamlined commissioning arrangements to enable a single set of commissioning decisions at system level. This will typically involve a single Clinical Commissioning Group (CCG) for each ICS area”. However, this will need to reflect local circumstances, and NHS England is not intending to impose this centrally. NHS England is working with ICS and local areas to determine the best configuration of CCGs.</p><p>CCGs have a legal right to apply for a merger and it is for NHS England to decide whether to approve a merger. This is an operational decision, and so sits with NHS England. There are a number of specific legal factors and further criteria that NHS England will consider when deciding whether to agree the merger. The application process and criteria applied for CCG mergers is available in the Procedures for clinical commissioning groups to apply for constitution change, merger or dissolution guidance.</p><p>The criteria include the proposed new CCG demonstrating alignment with (or within) the local STP/ICS to provide the most logical footprint for local implementation of the NHS Long Term Plan. CCGs must also include evidence of providing strategic, integrated commissioning to support population health; whilst ensuring that the move to a larger geographical footprint will not be at the expense of local accountability, or the proposed new CCG’s ability to engage with, and consider the needs of, local communities. Before a merger takes place, the CCG must also demonstrate that they have engaged with and seriously considered the views of their local general practitioners and local Healthwatch. In all cases, CCGs’ legal accountability to NHS England remains the same, regardless of the size of the CCG.</p><p>More broadly, we support NHS England’s intention to streamline commissioning arrangements, as NHS England expect that this will make it easier for the NHS to manage resources, make strategic decisions, and reduce unnecessary bureaucracy.</p><p> </p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 269781 269782 269784 269785 question first answered 05/07/2019 13:24:50 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4620 label Biography information for Ellie Reeves

1134902

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Commissioning Groups
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS long-term plan, what assessment he has made of the potential effect on local accountability in planning and commissioning health services of reducing the number of clinical commissioning groups to match the number of sustainability and transformation partnerships.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	269784
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>Sustainability and transformation partnerships (STPs) and integrated care systems (ICS) are fundamentally about bringing National Health Service providers, commissioners, local authorities, and other health and care services together to propose how they, at local level, can improve the way that health and care is planned and delivered in a more person-centred and coordinated way.</p><p>The most developed STPs have evolved into ICS, an even closer partnership between NHS organisations, local councils and other relevant organisations, which take collective responsibility for managing resources, delivering NHS standards, and improving the health of the population they serve.</p><p>The NHS Long Term Plan set out the ambition for ICS to cover the whole of England by April 2021. The NHS Long Term Plan sets out that “every ICS will need streamlined commissioning arrangements to enable a single set of commissioning decisions at system level. This will typically involve a single Clinical Commissioning Group (CCG) for each ICS area”. However, this will need to reflect local circumstances, and NHS England is not intending to impose this centrally. NHS England is working with ICS and local areas to determine the best configuration of CCGs.</p><p>CCGs have a legal right to apply for a merger and it is for NHS England to decide whether to approve a merger. This is an operational decision, and so sits with NHS England. There are a number of specific legal factors and further criteria that NHS England will consider when deciding whether to agree the merger. The application process and criteria applied for CCG mergers is available in the Procedures for clinical commissioning groups to apply for constitution change, merger or dissolution guidance.</p><p>The criteria include the proposed new CCG demonstrating alignment with (or within) the local STP/ICS to provide the most logical footprint for local implementation of the NHS Long Term Plan. CCGs must also include evidence of providing strategic, integrated commissioning to support population health; whilst ensuring that the move to a larger geographical footprint will not be at the expense of local accountability, or the proposed new CCG’s ability to engage with, and consider the needs of, local communities. Before a merger takes place, the CCG must also demonstrate that they have engaged with and seriously considered the views of their local general practitioners and local Healthwatch. In all cases, CCGs’ legal accountability to NHS England remains the same, regardless of the size of the CCG.</p><p>More broadly, we support NHS England’s intention to streamline commissioning arrangements, as NHS England expect that this will make it easier for the NHS to manage resources, make strategic decisions, and reduce unnecessary bureaucracy.</p><p> </p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 269781 269782 269783 269785 question first answered 05/07/2019 13:24:50 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4620 label Biography information for Ellie Reeves

1134903

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Commissioning Groups
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to (a) monitor and (b) evaluate the merit of mergers between clinical commissioning groups.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	269785
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>Sustainability and transformation partnerships (STPs) and integrated care systems (ICS) are fundamentally about bringing National Health Service providers, commissioners, local authorities, and other health and care services together to propose how they, at local level, can improve the way that health and care is planned and delivered in a more person-centred and coordinated way.</p><p>The most developed STPs have evolved into ICS, an even closer partnership between NHS organisations, local councils and other relevant organisations, which take collective responsibility for managing resources, delivering NHS standards, and improving the health of the population they serve.</p><p>The NHS Long Term Plan set out the ambition for ICS to cover the whole of England by April 2021. The NHS Long Term Plan sets out that “every ICS will need streamlined commissioning arrangements to enable a single set of commissioning decisions at system level. This will typically involve a single Clinical Commissioning Group (CCG) for each ICS area”. However, this will need to reflect local circumstances, and NHS England is not intending to impose this centrally. NHS England is working with ICS and local areas to determine the best configuration of CCGs.</p><p>CCGs have a legal right to apply for a merger and it is for NHS England to decide whether to approve a merger. This is an operational decision, and so sits with NHS England. There are a number of specific legal factors and further criteria that NHS England will consider when deciding whether to agree the merger. The application process and criteria applied for CCG mergers is available in the Procedures for clinical commissioning groups to apply for constitution change, merger or dissolution guidance.</p><p>The criteria include the proposed new CCG demonstrating alignment with (or within) the local STP/ICS to provide the most logical footprint for local implementation of the NHS Long Term Plan. CCGs must also include evidence of providing strategic, integrated commissioning to support population health; whilst ensuring that the move to a larger geographical footprint will not be at the expense of local accountability, or the proposed new CCG’s ability to engage with, and consider the needs of, local communities. Before a merger takes place, the CCG must also demonstrate that they have engaged with and seriously considered the views of their local general practitioners and local Healthwatch. In all cases, CCGs’ legal accountability to NHS England remains the same, regardless of the size of the CCG.</p><p>More broadly, we support NHS England’s intention to streamline commissioning arrangements, as NHS England expect that this will make it easier for the NHS to manage resources, make strategic decisions, and reduce unnecessary bureaucracy.</p><p> </p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 269781 269782 269783 269784 question first answered 05/07/2019 13:24:50 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4620 label Biography information for Ellie Reeves

1135217

	registered interest
	date	27/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Iron and Steel
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will sign his Department up to the UK Steel charter.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	270357
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>The Department supports the Charter where this is relevant to our commercial activities and only where consistent with the relevant procurement regulations that require fair and open competition.</p><p>The Parliamentary Undersecretary of State at the Department for Business, Energy and Industrial Strategy (Andrew Stephenson MP), wrote to the Secretary of State for Health and Social Care on 29 May to ask the Department to sign the Steel Charter. We are not aware of any further formal discussions on the topic. On matters relating to procurement policy, Departmental officials continue to work with officials in the Domestic Policy Team at Cabinet Office.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 270361 question first answered 05/07/2019 09:02:31 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4056 label Biography information for Nic Dakin